Affiliation: University of Foggia
- Twelve years of experience treating Spigelian herniaFrancesco A Polistina
Department of General Surgery, Monselice Hospital, Monselice, Italy Electronic address
Surgery 157:547-50. 2015..Patients may experience pain or a bulge in the abdominal area, but in most cases there are no symptoms. If left untreated the hernia may become strangulated, which could lead to bowel obstruction...
- Sporadic, nontrauma-related, desmoid tumor of the pancreas: a rare disease-case report and literature reviewF Polistina
Emergency and Trauma Department, Dolo Hospital, Dolo, 30031 Venice, Italy
Case Report Med 2010:272760. 2010..The patient underwent resection with no further treatment and remain disease-free 60 months after surgery...
- Unresectable locally advanced pancreatic cancer: a multimodal treatment using neoadjuvant chemoradiotherapy (gemcitabine plus stereotactic radiosurgery) and subsequent surgical explorationFrancesco Polistina
Department of Surgery, San Bortolo Hospital, Vicenza, Italy
Ann Surg Oncol 17:2092-101. 2010..We conducted a prospective, nonrandomized study of patients with LAPC to assess the effect of stereotactic body radiotherapy (SBRT) on local response, pain control, and quality of life (QOL)...
- Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experienceFrancesco Antonio Polistina
Department of Trauma and Surgical Emergencies, Dolo Hospital, Venice, Italy
Radiother Oncol 99:120-3. 2011..We present the results of hypofractionated Stereotactic Body Radiotherapy (SBRT) on a small series of non resectable locally advanced KT patients...
- Aggressive treatment for hepatic metastases from breast cancer: results from a single centerF Polistina
Department of General and Oncologic Surgery, Monselice Hospital, Via G Marconi, 35043, Monselice, Italy
World J Surg 37:1322-32. 2013..Patients with isolated BCLM have the poorest prognosis with a median survival ranging from 19 to 26 months...